The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday September 26, 2016:
Disney Said to Work With Advisor on Bid for Twitter
The Rumor:
Shares of Twitter (NYSE: TWTR) spiked higher Monday following
a report from Bloomberg, that Disney (NYSE: DIS) has
hired an advisor and may bid for the social media company. Disney is the latest potential buyer mentioned in the past week, joining
Alphabet (NASDAQ: GOOGL) and salesforce.com, inc. (NYSE:
CRM). Later, CNBC's David Faber said Microsoft (NASDAQ:
MSFT) was a possible bidder, while Facebook (NASDAQ:
FB) was not likely interested. Faber said a deal could happen
in the next 30 to 45 days.
Twitter closed at $23.37 on Monday, up 3.32%.
Green Plains Partners Acquires Abengoa Ethanol Storage Assets for $90M
The Deal:
Green Plains Partners LP (NASDAQ: GPP) announced Monday, that
it acquired the ethanol storage assets associated with the Madison, IL, Mount Vernon, IN and York, NE production facilities from
Green Plains Inc. (NASDAQ: GPRE) for $90 million. The
storage assets were simultaneously purchased and sold by Green Plains as part of the $237 million purchase of three ethanol plants
previously owned by Abengoa Bioenergy.
Green Plains Partners closed at $19.12 on Monday, down 1.29%.
CBOE Holdings to Acquire Bats Global Markets for $32.50/Share
The Deal:
CBOE Holdings, Inc. (NASDAQ: CBOE) and Bats Global Markets,
Inc. (NASDAQ: BATS) announced Monday, that they have entered
into a definitive agreement under which CBOE Holdings will acquire Bats for approximately $32.50 per Bats share, for a total of
approximately $3.2 billion. Bats shareholders will receive $10.00 per share in cash and 0.3201 of a share of CBOE Holdings common
stock. The transaction is expected to close in H1 of 2017.
Bats closed at $30.35 on Monday, down 4.56%.
Mylan, Lupin Said to be Considering Bids for Bayer's Dermatology Unit
The Rumor:
Mylan NV (NYSE: MYL) and Lupin Ltd. are among the companies
considering bidding for Bayer’s (OTC: BAYRY) dermatology
business, according to sources as reported by Bloomberg on Monday. Bayer is selling the unit in order to raise cash ahead of
its acquisition of Monsanto (NYSE: MON). Bayer and Lupin
declined comment, while Mylan did not immediately respond.
Mylan closed at $41.18 on Monday, down 2.09%.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.